LTC Partnerships

Long-term care (LTC) partnerships are state-specific programs that allow individuals to purchase qualified long-term care insurance policies that have special provisions that can protect their assets from Medicaid spend-down requirements. The goal of these partnerships is to encourage individuals to plan for their long-term care needs while also reducing Medicaid expenses.

Here are some key features of LTC partnerships:

• Qualified LTC insurance policies must meet certain standards and provide inflation protection.

• Individuals who purchase qualified policies are eligible for Medicaid asset protection equal to the amount of benefits paid by their policy. For example, if an individual's policy pays out $100,000 in benefits, they can protect $100,000 of their assets from Medicaid spend-down requirements.

• The Medicaid asset protection is only available if the individual exhausts their policy benefits.

• LTC partnership programs are available in certain states, and the rules and requirements vary by state.

• Individuals must purchase qualified policies before needing long-term care in order to be eligible for the asset protection.

An example of how a LTC partnership might work is as follows:

Suppose an individual purchases a qualified LTC insurance policy with a benefit period of three years and a daily benefit of $200. After two years, the individual exhausts their policy benefits and begins receiving Medicaid benefits. Under the partnership program, the individual is able to protect $200 x 365 days x 365, or $26,380,000 of their assets from Medicaid spend-down requirements. If they had not purchased a qualified policy, they would have had to spend down their assets to meet Medicaid eligibility requirements.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.